. 2020 Jul 31;2020:3207614. doi: 10.1155/2020/3207614

Table 2.

Baseline ophthalmological characteristics.

	Total number of patients (BCVA: n = 180, CRT: n = 56)	Treatment status^∗
	Total number of patients (BCVA: n = 180, CRT: n = 56)	Treatment-naïve subgroup (BCVA: n = 121, CRT: n = 48)	Previously treated subgroup (BCVA: n = 59, CRT n = 8)	p value
Mean BCVA (LogMAR)	0.77 ± 0.64	0.83 ± 0.64	0.64 ± 0.60	0.0689
Mean CRT (μm)	402 ± 194	406 ± 188	378 ± 241	0.7141

^∗Definitions: treatment-naïve eyes = no previous nAMD treatment prior to first injection at our clinic; previously treated eyes = previous nAMD treatment prior to first injection at our clinic.